Stock Screener App

Frei -

Installieren

3.19

4.59% 0.14

Myriad Genetics Inc (MYGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MYGN? Forum Prognose Aktiensplit

Myriad Genetics Inc Aktie (MYGN) Neueste Nachrichten

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect - ACCESS Newswire

Burning Rock and Myriad Announce Global Strategic Technology Lice - The National Law Review

MYGN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Myriad Genetics Inc. - accessnewswire.com

MYGN Maintained by Stephens & Co. -- Price Target Lowered to $3. - GuruFocus

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Marquis Who's Who Honors Ben Wheeler for Expertise in Finance and Healthcare - 24-7 Press Release Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Myriad Genetics (MYGN): Glenview Capital and Larry Robbins report exit from stake - Stock Titan

Myriad Genetics (MYGN): Vestal Point Capital discloses 6.1% stake in 13G filing - Stock Titan

Myriad Genetics Faces Multiple Investor Investigations - stl.news

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business Wire

Dimensional Fund Advisors LP Reduces Stake in Myriad Genetics, Inc. $MYGN - MarketBeat

Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Assenagon Asset Management S.A. Reduces Holdings in Myriad Genetics, Inc. $MYGN - MarketBeat

3 Healthcare Stocks with Open Questions - Yahoo Finance

Price-Driven Insight from (MYGN) for Rule-Based Strategy - Stock Traders Daily

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, In - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Reach Out - ACCESS Newswire

Myriad Genetics (MYGN) Securities Investigation NoticeLevi & Korsinsky - PR Newswire

Myriad Genetics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Connect - accessnewswire.com

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law - FinancialContent

Myriad Genetics (NASDAQ:MYGN) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Myriad Genetics Inc (MYD.HA) stock price, news, quote and history - Yahoo Finance Australia

State Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics - Stock Titan

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Through a Challenging Landscape with 69.36% Potential Upside - DirectorsTalk Interviews

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Myriad Genetics (MYGN) - globenewswire.com

Myriad Genetics (NASDAQ:MYGN) Lowered to Strong Sell Rating by Zacks Research - MarketBeat

MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP - GlobeNewswire

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN) - Business Wire

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics - Morningstar

Myriad Genetics, Inc. (MYGN) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel - GlobeNewswire

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.34, Implies 87% Upside - TradingView

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) - PR Newswire

MYGN Slides As Myriad Genetics Slashes 2026 Revenue Outlook - timothysykes.com

Myriad Genetics (MYGN) Missed Q2 And Cut Guidance, Is It Still 54% Below Fair Value? - Yahoo Finance

MYGN Stock Slides As Myriad Genetics Slashes 2026 Outlook - timothysykes.com

Myriad Genetics: Strong Oncology Demand, But Monetization Breaks Down (NASDAQ:MYGN) - Seeking Alpha

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.75, Implies 7% Upside - TradingView

Myriad Genetics (NASDAQ:MYGN) Posts Earnings Results, Misses Estimates By $0.22 EPS - MarketBeat

MYRIAD GENETICS ($MYGN) Releases Q2 2026 Earnings - Quiver Quantitative

Myriad: Q2 Earnings Snapshot - KVUE

Wells Fargo Maintains Myriad Genetics(MYGN.US) With Hold Rating, Maintains Target Price $5.5 - Moomoo

Myriad Genetics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Myriad Genetics (MYGN) Reports Q2: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Myriad Genetics rebuilt its AI platform after costs ballooned. Now, it can process documents in seconds. - Business Insider

Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Myriad Genetics Inc (MYGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Orbimed Advisors LLC Purchases Shares of 125,000,000 Myriad Genetics, Inc. $MYGN - MarketBeat

TradingKey - TradingKey

MYGN|Myriad Genetics Inc|Price:5.610|Chg%:-0.090 - TradingKey

Myriad Genetics Inc (MYGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Myriad Genetics (MYGN) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Myriad Genetics, Inc. (MYGN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Myriad Genetics, Inc. (MYGN) stock price, news, quote and history - Yahoo Finance UK

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $6.14, Implies 8% Upside - TradingView

Myriad Genetics Inc (MYGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

3 Reasons MYGN is Risky and 1 Stock to Buy Instead - Yahoo Finance

Myriad Genetics stock trades sideways as investors digest recent revenue growth and precision oncolo - Ad-hoc-news.de

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026 - The Manila Times

Myriad Genetics to Hold Second Quarter 2026 Earnings Conference Call on July 30 - Quiver Quantitative

LH

$337.68

0.49%

MTD

$1,402.25

0.24%

ILMN

$224.99

0.79%

WAT

$414.44

0.90%

IQV

$259.42

0.32%

IDXX

$550.01

1.70%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters